Transient Ischemic Attack News and Research

RSS
A transient ischemic attack (TIA) is a transient stroke that lasts only a few minutes. It occurs when the blood supply to part of the brain is briefly interrupted. TIA symptoms, which usually occur suddenly, are similar to those of stroke but do not last as long. Most symptoms of a TIA disappear within an hour, although they may persist for up to 24 hours. Symptoms can include: numbness or weakness in the face, arm, or leg, especially on one side of the body; confusion or difficulty in talking or understanding speech; trouble seeing in one or both eyes; and difficulty with walking, dizziness, or loss of balance and coordination.
Ampio announces results from Optina trial on DME

Ampio announces results from Optina trial on DME

Experts validate promising alternative to Framingham risk score for UK

Experts validate promising alternative to Framingham risk score for UK

Diagnosis, not risk stratification, advised for TIA patients

Diagnosis, not risk stratification, advised for TIA patients

Short sleep periods increase risk of stroke in normal-weight adults

Short sleep periods increase risk of stroke in normal-weight adults

Study confirms linear association between JBA and future stroke rate

Study confirms linear association between JBA and future stroke rate

Rheumatoid arthritis drug has added benefits

Rheumatoid arthritis drug has added benefits

Posttraumatic stress hits stroke secondary prevention

Posttraumatic stress hits stroke secondary prevention

Studies examine effectiveness of CPAP in reducing risk of cardiovascular outcomes linked with OSA

Studies examine effectiveness of CPAP in reducing risk of cardiovascular outcomes linked with OSA

Mylan receives final FDA approval for Clopidogrel Tablets ANDA

Mylan receives final FDA approval for Clopidogrel Tablets ANDA

Current anticoagulant therapy to prevent stroke might not be sufficient for older women with AF

Current anticoagulant therapy to prevent stroke might not be sufficient for older women with AF

Otsuka announces results from aripiprazole Phase 3 trial on schizophrenia

Otsuka announces results from aripiprazole Phase 3 trial on schizophrenia

Fish oil not as beneficial for the heart as thought: Study

Fish oil not as beneficial for the heart as thought: Study

Depression more prevalent among stroke and transient ischemic attack survivors

Depression more prevalent among stroke and transient ischemic attack survivors

Patients worried about statin use after label warnings from FDA

Patients worried about statin use after label warnings from FDA

CT scan as effective as MRI in predicting recurrent stroke risk

CT scan as effective as MRI in predicting recurrent stroke risk

Slow walk and poor grip may predict dementia and stroke

Slow walk and poor grip may predict dementia and stroke

Simple tests may help doctors determine risk of dementia, stroke in middle-aged people

Simple tests may help doctors determine risk of dementia, stroke in middle-aged people

UCLA professor receives ASA's Feinberg Award for clinical stroke research

UCLA professor receives ASA's Feinberg Award for clinical stroke research

Aspirin and warfarin similar in preventing deaths and strokes in heart failure patients

Aspirin and warfarin similar in preventing deaths and strokes in heart failure patients

New drug might effectively prevent clot-related strokes in patients with AF

New drug might effectively prevent clot-related strokes in patients with AF

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.